Insider Transactions in Q4 2022 at Bio Rad Laboratories, Inc. (BIO)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2022
|
Dara Wright EVP, President, CDG |
SELL
Payment of exercise price or tax liability
|
Direct |
226
-11.37%
|
$91,982
$407.98 P/Share
|
|
Dec 16
2022
|
Dara Wright EVP, President, CDG |
BUY
Exercise of conversion of derivative security
|
Direct |
502
+20.17%
|
-
|
|
Nov 10
2022
|
Ajit Ramalingam SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
379
-85.22%
|
$159,938
$422.53 P/Share
|
|
Nov 07
2022
|
Steven D Schwartz > 10% Shareholder |
BUY
Bona fide gift
|
Indirect |
42
+0.32%
|
-
|
|
Nov 07
2022
|
Steven D Schwartz > 10% Shareholder |
BUY
Bona fide gift
|
Direct |
42
+0.17%
|
-
|
|
Nov 07
2022
|
Norman D Schwartz Chairman & CEO |
BUY
Bona fide gift
|
Indirect |
42
+0.32%
|
-
|
|
Nov 07
2022
|
Norman D Schwartz Chairman & CEO |
BUY
Bona fide gift
|
Direct |
42
+0.01%
|
-
|
|
Nov 07
2022
|
Schwartz Allison Director |
BUY
Bona fide gift
|
Direct |
42
+1.07%
|
-
|
|
Nov 07
2022
|
Alice N Schwartz > 10% Shareholder |
SELL
Bona fide gift
|
Indirect |
252
-0.06%
|
-
|
|
Nov 07
2022
|
Alice N Schwartz > 10% Shareholder |
SELL
Bona fide gift
|
Indirect |
2,639
-0.15%
|
-
|